Chris Xu
2020
In 2020, Chris Xu earned a total compensation of $2M as Chief Executive Officer at Cesca Therapeutics, a 323% increase compared to previous year.
Compensation breakdown
| Bonus | $276,000 |
|---|---|
| Option Awards | $1,216,000 |
| Salary | $505,000 |
| Total | $1,997,000 |
Xu received $1.2M in option awards, accounting for 61% of the total pay in 2020.
Xu also received $276K in bonus and $505K in salary.
Rankings
In 2020, Chris Xu's compensation ranked 5,520th out of 13,090 executives tracked by ExecPay. In other words, Xu earned more than 57.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,520 out of 13,090 | 58th |
Division Manufacturing | 2,273 out of 5,621 | 60th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 285 out of 799 | 64th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 98 out of 227 | 57th |
Industry Laboratory Apparatus and Furniture | 1 out of 5 | 80th |
Source: SEC filing on November 5, 2021.
Xu's colleagues
We found one more compensation record of an executive who worked with Chris Xu at Cesca Therapeutics in 2020.
2020
Jeffery Cauble
Cesca Therapeutics
Chief Financial Officer
News
Cesca Therapeutics CEO Chris Xu's 2022 pay slips 7% to $699K
October 26, 2023
Cesca Therapeutics CEO Chris Xu's 2021 pay falls 63% to $748K
November 1, 2022
Cesca Therapeutics CEO Chris Xu's 2020 pay jumps 323% to $2M
November 5, 2021
Cesca Therapeutics CEO Chris Xu's 2019 pay falls 28% to $472K
April 21, 2020